Management ChangeJun 23, 2026, 04:07 PM
IDEAYA Biosciences Elects New Chairman, Lead Independent Director
AI Summary
IDEAYA Biosciences, Inc. held its 2026 Annual Meeting of Stockholders on June 16, 2026, where shareholders voted on three proposals. All three Class I directors, Yujiro S. Hata, M. Garret Hampton, Ph.D., and Catherine J. Mackey, Ph.D., were elected to serve until the 2029 annual meeting. Stockholders also ratified PricewaterhouseCoopers LLP as the independent auditor and approved the non-binding advisory vote on executive compensation. Following the meeting, the Board of Directors elected Yujiro S. Hata as Chairman of the Board and Terry Rosen, Ph.D., as the Lead Independent Director.
Key Highlights
- Yujiro S. Hata elected as Chairman of the Board, effective June 16, 2026.
- Terry Rosen, Ph.D., elected as Lead Independent Director, effective June 16, 2026.
- Yujiro S. Hata, M. Garret Hampton, Ph.D., and Catherine J. Mackey, Ph.D., were elected as Class I directors.
- Stockholders ratified PricewaterhouseCoopers LLP as independent auditor with 82,579,758 votes For.
- Stockholders approved the non-binding advisory vote on executive compensation with 64,269,756 votes For.
- The Annual Meeting of Stockholders was held on June 16, 2026.
- 87,860,920 shares of common stock were outstanding and entitled to vote as of the record date.
Price Impact
More from IDYA